Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Anglo American committed to Aussie coal sale after Moranbah North stoppage

(Sharecast News) - Anglo American confirmed in an update on Tuesday that it does not expect the recent stoppage at its Moranbah North mine to trigger a material adverse change clause in its agreement to sell its Australian steelmaking coal assets to Peabody Energy. The FTSE 100 mining giant said it was committed to completing the transaction, adding that it is working with Peabody to address outstanding conditions.

Operations at Moranbah North were halted following a contained ignition event in the goaf on 31 March, prompting the safe withdrawal of all personnel.

Initial re-entry was completed on 19 April, and Anglo American said it was now working closely with Queensland's safety regulator and other stakeholders on a phased plan to resume longwall production once it is deemed safe.

Anglo American said that, based on progress made so far and the available information, it did not consider the incident to constitute a material adverse change under the definitive sale agreements announced in November.

The company reiterated its intention to satisfy the remaining customary conditions necessary to complete the deal.

At 1101 BST, shares in Anglo American were down 3.93% at 2,052p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.